Exploring new chemical tools to study NEK kinases in cancer
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer
This study is looking at special proteins called NEK kinases that play a role in cancer, and it's working to create new tools to help scientists learn more about how these proteins work, which could lead to better treatments for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10983823 on NIH RePORTER |
What this research studies
This research focuses on the NEK family of kinases, which are important proteins involved in regulating various biological processes related to cancer. The project aims to develop specific chemical probes and inhibitors that can help scientists better understand how these kinases function and their roles in cancer development. By creating advanced assays and molecular tools, the research seeks to uncover the connections between NEK kinases and different types of cancer, potentially leading to new treatment strategies. Patients may benefit from the insights gained through this research as it could pave the way for targeted cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers that may be influenced by NEK kinases.
Not a fit: Patients with cancers unrelated to NEK kinases or those not currently undergoing treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new targeted therapies for various cancers.
How similar studies have performed: Previous research has shown success in targeting other kinase families for cancer treatment, suggesting potential for similar breakthroughs with NEK kinases.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Drewry, David Harold — Univ of North Carolina Chapel Hill
- Study coordinator: Drewry, David Harold
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.